Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 12.3% in the afternoon session after the company reported fourth-quarter 2025 financial results that beat analyst estimates and ...

Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting services ...

Shares of scientific consulting firm Exponent (NASDAQ:EXPO) jumped 2.3% in the morning session after JPMorgan initiated coverage on the company with an 'Overweight' rating and a $100 price target. The ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. If you are wondering whether Exponent is fairly priced or ...

Exponent (EXPO) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.5 per share. This compares to earnings of $0.5 per share a year ago. These figures are ...

Good day, and welcome to Exponent Second Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Joni ...

Jasper Bibb - Truist Securities, Inc. Andrew Nicholas - William Blair & Company L.L.C. Good afternoon, everyone, and welcome to the Exponent, Inc. Q3 2024 Earnings Conference Call. All participants ...

Good day and welcome to the Exponent, Inc. First Quarter 2025 Earnings Conference Call. All participants will be in the listen-only mode. [Operator Instructions] Please note, this event is being ...

Good afternoon and welcome to the Exponent, Second Quarter 2024 Earnings Conference Call. All participants will be in listen only mode. [Operator Instructions] Please note this event is being recorded ...

Good day, and welcome to the Exponent, Inc. Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over ...